INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group

(NASDAQ:HUBG), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Hub Group To Contact Him Directly To Discuss Their Options If you suffered significant losses in Hub Group stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly […]

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group GlobeNewswire February 06, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Hub Group To Contact Him Directly To Discuss Their Options If you suffered significant losses in Hub Group stock

Halper Sadeh LLC is Investigating Whether ALGT, EB, COUR are Obtaining Fair Prices for its Shareholders

Insiders may stand to receive substantial financial benefits that are not available to ordinary shareholders. The transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights at no cost or obligation. Halper Sadeh LLC, an investor rights law firm, is investigating the following companies

Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela RiaƱo Caro

Regional program delivers double-digit sales growth, improved service performance, and expanded diagnostic access across Latin America Abbott Laboratories today announced the successful completion of a multi-country diagnostic market development and professional training initiative across Latin America, delivering measurable commercial growth, improved service performance, and expanded access to advanced diagnostic technologies in key regional markets. “Innovation

Anfield Energy Announces Special Shareholder Meeting and Mailing of Related Documents

(TSX-V:AEC),(Boerse Frankfurt – Freiverkehr:0AD),(NASDAQ:AEC),(Boerse Frankfurt – Freiverkehr:0ADN),(NYSE:UEC), VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”) announces that today is the legal mailing date for the mailing and filing of the notice of a meeting of shareholders, the management information circular, and

Aldebaran Grants Incentive Stock Options

(TSX-V:ALDE),(TSX-V:ALDE.V),(OTC US:ADBRF),(Other OTC:ADBRF), VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) — Aldebaran Resources Inc. (the “Company“) (TSX-V: ALDE, OTCQX: ADBRF) announces that incentive stock options have been granted to directors, officers, employees and consultants to purchase up to 3,990,000 common shares at a price of $3.25 per share for five years, pursuant to its

Onex Completes Convex Acquisition and Strategic Investment by AIG

(TSX:ONEX), All amounts in U.S. dollars unless otherwise stated TORONTO, Feb. 06, 2026 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced the completion of its previously announced acquisition of Convex Group Limited (“Convex”), a leading specialty property and casualty insurance and reinsurance company. “This is a pivotal moment in Onex' history and the addition

SOLOWIN HOLDINGS Collaborates with Alibaba Taobao Shangou and Hangzhou Bossen to Advance Inclusive Carbon Reduction via Blockchain

(NASDAQ:AXG), Hong Kong, Feb. 06, 2026 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (Nasdaq: AXG) (“AXG” or the “Company”), a leading financial technology firm bridging traditional and digital assets, today announced a partnership with Taobao Shangou,a subsidiary of Alibaba Group and Hangzhou Bossen, to implement an innovative model integrating “high-quality carbon assets + consumer platform incentives +

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:ORIC), SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on February 2, 2026 (the “Grant Date”), ORIC granted a total of 173,800 non-qualified stock options and 28,700 restricted

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NasdaqGM:FULC), CAMBRIDGE, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.(R) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to one new employee. Fulcrum granted stock options to purchase shares of

Scroll to Top